Qvr LLC Eli Lilly & CO Call Options Transaction History

Qvr LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $4.63 Million - $5.4 Million	-14,400 Reduced 96.64%	500 $182,000
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $1.66 Million - $1.89 Million	5,600 Added 60.22%	14,900 $4.82 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $4.29 Million - $5.04 Million	-15,400 Reduced 62.35%	9,300 $3.02 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $5.8 Million - $7.2 Million	24,700 New	24,700 $7.08 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $1.33 Million - $1.65 Million	-5,900 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $709,120 - $872,671	3,200 Added 118.52%	5,900 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $216,660 - $280,248	1,200 Added 80.0%	2,700 $621,000
Q1 2021 May 03, 2021	BUY	$164.32 - $212.72 $115,024 - $148,904	700 Added 87.5%	1,500 $280,000
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $104,368 - $138,104	800 New	800 $136,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.